drugset / Trial / NCT01311570
Study Assessing the Safety and Therapeutic Effect of Buprenorphine in MDD Patients
NaSingle-groupOpen-labelTreatment
Summary
The primary objective of this study is to assess the therapeutic effect of Buprenorphine in MDD population. The secondary objectives of this study are to assess the therapeutic effect, the feasibility and safety of buprenorphine in a MDD population.
Timeline
- Start
- 2012-10
- Primary completion
- 2013-02
- Completion
- —
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Buprenorphine | Other / unclassified | 4 mg | Other |
| Subject | Buprenorphine | Other / unclassified | 8 mg | Other |